Brandon Miller serves as CEO of IcelandirectSoma Labs was established in 1998
Icelandirect, a portfolio company of New Heritage Capital, has acquired Soma Labs, a New Jersey-based supplement manufacturer specializing in solid dosage form production. No financial terms were disclosed.
Icelandirect is a US-based contract manufacturer of human and pet supplement brands.
“For years, we have been known as a leader in lipid and softgel supplement sourcing, formulation, manufacturing and packaging,” said Brandon Miller, CEO of Icelandirect in a statement. “The acquisition of Soma Labs will allow us to add powder, tablet, capsule, and chewable capabilities, thus delivering a turnkey product offering to our clients. These new offerings allow us to take a brand from ingredient and formula all the way through to finished, shelf-ready product — in more formats, at greater scale, and with the quality standards our customers have come to expect from Icelandirect.”
Soma Labs will operate as an integrated division of Icelandirect, with its New Jersey facility remaining fully operational.
Soma Labs was established in 1998.
